BDBM106980 US8592454, 233

SMILES COC(=O)N[C@H]1CC[C@H](C(=O)N2C[C@@H](N(C)C(=O)N(C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@H](c3ccc(F)cc3)C2)CC1

InChI Key InChIKey=HUBLDDBZWROLJY-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 106980   

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 106980BDBM106980(US8592454, 233)
Affinity DataIC50: 0.0490nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 106980BDBM106980(US8592454, 233)
Affinity DataIC50: 42nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 106980BDBM106980(US8592454, 233)
Affinity DataIC50: 1.10E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
US Patent